Enrico Cacace

861 total citations
23 papers, 544 citations indexed

About

Enrico Cacace is a scholar working on Psychiatry and Mental health, Genetics and Pharmacology. According to data from OpenAlex, Enrico Cacace has authored 23 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Genetics and 5 papers in Pharmacology. Recurrent topics in Enrico Cacace's work include Fibromyalgia and Chronic Fatigue Syndrome Research (10 papers), Hemoglobinopathies and Related Disorders (6 papers) and Musculoskeletal pain and rehabilitation (4 papers). Enrico Cacace is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (10 papers), Hemoglobinopathies and Related Disorders (6 papers) and Musculoskeletal pain and rehabilitation (4 papers). Enrico Cacace collaborates with scholars based in Italy, Brazil and United States. Enrico Cacace's co-authors include G. La Montagna, Valeria Ruggiero, Silvano Adami, Maurizio Rossini, Ombretta Di Munno, Susanna Maddali Bongi, Nazzarena Malavolta, Giovanni Minisola, L. Sinigaglia and Luigi F. Bernini and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Enrico Cacace

22 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrico Cacace Italy 12 214 135 88 83 74 23 544
Şeref Demirkaya Türkiye 14 172 0.8× 212 1.6× 43 0.5× 14 0.2× 8 0.1× 54 698
Marina Titlić Croatia 13 82 0.4× 59 0.4× 18 0.2× 17 0.2× 18 0.2× 75 524
Stephen Trevick United States 7 164 0.8× 135 1.0× 17 0.2× 14 0.2× 13 0.2× 8 591
Alan Moore Switzerland 13 528 2.5× 93 0.7× 136 1.5× 9 0.1× 25 0.3× 28 1.0k
Lei Fang China 13 57 0.3× 73 0.5× 64 0.7× 17 0.2× 14 0.2× 38 458
Kati Otsa Estonia 12 79 0.4× 421 3.1× 15 0.2× 123 1.5× 13 0.2× 15 881
Alex Allen United Kingdom 6 84 0.4× 29 0.2× 183 2.1× 13 0.2× 12 0.2× 7 458
Michael A. Ueberall Germany 12 207 1.0× 68 0.5× 134 1.5× 5 0.1× 47 0.6× 28 588
Pelin Oktayoğlu Türkiye 13 153 0.7× 43 0.3× 67 0.8× 22 0.3× 4 0.1× 32 466
G. Veyrac France 11 67 0.3× 34 0.3× 198 2.3× 28 0.3× 5 0.1× 41 531

Countries citing papers authored by Enrico Cacace

Since Specialization
Citations

This map shows the geographic impact of Enrico Cacace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Cacace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Cacace more than expected).

Fields of papers citing papers by Enrico Cacace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Cacace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Cacace. The network helps show where Enrico Cacace may publish in the future.

Co-authorship network of co-authors of Enrico Cacace

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Cacace. A scholar is included among the top collaborators of Enrico Cacace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Cacace. Enrico Cacace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mela, Quirico, Valeria Ruggiero, Simona Onali, et al.. (2018). Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?. HIV Clinical Trials. 19(5). 188–196. 3 indexed citations
2.
Carta, Mauro Giovanni, Maria Francesca Moro, Francesco Pinna, et al.. (2018). The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life. International Journal of Social Psychiatry. 64(7). 647–655. 37 indexed citations
3.
Sancassiani, Federica, Sérgio Machado, Valeria Ruggiero, et al.. (2017). The management of fibromyalgia from a psychosomatic perspective: an overview. International Review of Psychiatry. 29(5). 473–488. 39 indexed citations
4.
Fais, Antonella, Enrico Cacace, Luigi Atzori, Benedetta Era, & Valeria Ruggiero. (2015). Plasma phospholipase, γ‐CEHC and antioxidant capacity in fibromyalgia. International Journal of Rheumatic Diseases. 20(5). 550–554. 8 indexed citations
5.
Caboni, Pierluigi, Barbara Liori, Amit Kumar, et al.. (2014). Metabolomics Analysis and Modeling Suggest a Lysophosphocholines-PAF Receptor Interaction in Fibromyalgia. PLoS ONE. 9(9). e107626–e107626. 54 indexed citations
6.
Ruggiero, Valeria, et al.. (2013). The Use of Antidepressants in the Long-Term Treatment Should not Improve the Impact of Fibromyalgia on Quality of Life. Clinical Practice and Epidemiology in Mental Health. 9(1). 120–124. 15 indexed citations
7.
Fais, Antonella, et al.. (2012). Purine metabolites in fibromyalgia syndrome. Clinical Biochemistry. 46(1-2). 37–39. 15 indexed citations
8.
Cacace, Enrico, et al.. (2011). Quality of life and associated clinical distress in fibromyalgia. Reumatismo. 58(3). 226–9. 5 indexed citations
9.
Rossini, Maurizio, Susanna Maddali Bongi, G. La Montagna, et al.. (2010). Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Research & Therapy. 12(6). R216–R216. 156 indexed citations
10.
Rossini, Maurizio, Ombretta Di Munno, Gabriele Valentini, et al.. (2007). Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.. PubMed. 25(2). 182–8. 48 indexed citations
11.
Carta, Mauro Giovanni, et al.. (2006). The high frequency of manic symptoms in fibromyalgia does influence the choice of treatment?. Clinical Practice and Epidemiology in Mental Health. 2(1). 36–36. 30 indexed citations
12.
Cacace, Enrico, et al.. (2006). Etanercept in Rheumatoid Arthritis: Long Term Anti-Inflammatory Efficacy in Clinical Practice. European Journal of Inflammation. 4(3). 171–176. 1 indexed citations
13.
Cacace, Enrico, et al.. (2006). Systemic mast cell disease: a rare cause of osteoporosis.. PubMed. 24(2). 210–210. 3 indexed citations
14.
Cacace, Enrico, et al.. (2003). Optic nerve compression by extramedullary hematopoietic tissue in a patient suffering from beta-thalassemia intermedia.. PubMed. 22-23. 5–6. 8 indexed citations
15.
Littera, Roberto, et al.. (2001). The role of heterocellular hereditary persistence of fetal haemoglobin in β0‐thalassaemia intermedia. British Journal of Haematology. 114(4). 899–906. 8 indexed citations
16.
Montagna, G. La, G Tirri, Enrico Cacace, et al.. (1998). Quality of life assessment during six months of NSAID treatment [Gonarthrosis and Quality of Life (GOAL) Study].. PubMed. 16(1). 49–54. 15 indexed citations
17.
Usai, P., et al.. (1995). Adult celiac disease is frequently associated with sacroiliitis. Digestive Diseases and Sciences. 40(9). 1906–1908. 22 indexed citations
18.
Galanello, R., MA Melis, Maria Addis, et al.. (1989). Molecular analysis of beta zero-thalassemia intermedia in Sardinia. Blood. 74(2). 823–827. 54 indexed citations
19.
Cacace, Enrico, et al.. (1986). [Etiopathogenesis and curative treatment of skin ulcer in intermediate beta-thalassemia].. PubMed. 1(1). 47–53. 1 indexed citations
20.
Passiu, Giuseppe, Quirico Mela, G Perpignano, Roberto Frigerio, & Enrico Cacace. (1984). Safety of flurbiprofen in subjects with G-6-PD deficiency. In vivo and in vitro results.. PubMed. 4(2). 137–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şeref Demirkaya Breakdown of academic impact, for papers by Marina Titlić Breakdown of academic impact, for papers by Stephen Trevick Breakdown of academic impact, for papers by Alan Moore Breakdown of academic impact, for papers by Lei Fang Breakdown of academic impact, for papers by Kati Otsa Breakdown of academic impact, for papers by Alex Allen Breakdown of academic impact, for papers by Michael A. Ueberall Breakdown of academic impact, for papers by Pelin Oktayoğlu Breakdown of academic impact, for papers by G. Veyrac
Rankless by CCL
2026